COVID-19

Coronavirus (COVID-19) Weekly Discussion: Interferons, Itolizumab, COVID-19 Management

Coronavirus (COVID-19) Weekly Discussion: Interferons, Itolizumab, COVID-19 Management

Weekly question and answer going over interferon study from UK from biotech company, Synairgen, Itolizumab and Lenzilumab mechanism of action and other COVID-19 topics such as current COVID-19 management in the hospital.

1. Interferon
2. Itolizumab (Biocon)
3. Lenzilumab (Humanigen)
4. Ventilator management